Evi Lianidou

10.7k total citations
206 papers, 8.3k citations indexed

About

Evi Lianidou is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Evi Lianidou has authored 206 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Cancer Research, 109 papers in Molecular Biology and 91 papers in Oncology. Recurrent topics in Evi Lianidou's work include Cancer Genomics and Diagnostics (82 papers), Cancer Cells and Metastasis (59 papers) and Epigenetics and DNA Methylation (40 papers). Evi Lianidou is often cited by papers focused on Cancer Genomics and Diagnostics (82 papers), Cancer Cells and Metastasis (59 papers) and Epigenetics and DNA Methylation (40 papers). Evi Lianidou collaborates with scholars based in Greece, United States and Germany. Evi Lianidou's co-authors include Athina Markou, Αreti Strati, Vassilis Georgoulias, Dimitris Mavroudis, Vassilis Georgoulias, Nikos Malamos, Maria Perraki, Stella Apostolaki, George M. Yousef and Aliki Stathopoulou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Evi Lianidou

202 papers receiving 8.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evi Lianidou Greece	52	5.1k	4.3k	3.5k	1.6k	816	206	8.3k
Harriet Wikman Germany	41	2.9k 0.6×	3.7k 0.9×	2.3k 0.6×	1.3k 0.8×	355 0.4×	122	6.5k
Yongqian Shu China	37	3.5k 0.7×	4.1k 1.0×	1.8k 0.5×	1.3k 0.8×	592 0.7×	189	6.9k
Steven Van Laere Belgium	45	2.5k 0.5×	2.6k 0.6×	2.7k 0.8×	968 0.6×	332 0.4×	161	5.6k
Edwin M. Posadas United States	41	1.9k 0.4×	2.7k 0.6×	1.9k 0.5×	1.9k 1.2×	611 0.7×	173	5.6k
Andrew P. Mazar United States	53	3.0k 0.6×	3.5k 0.8×	2.3k 0.6×	884 0.5×	368 0.5×	176	7.8k
Glen J. Weiss United States	44	1.9k 0.4×	4.2k 1.0×	3.1k 0.9×	1.9k 1.1×	349 0.4×	209	7.9k
Ruth O’Regan United States	42	1.8k 0.3×	3.2k 0.8×	3.0k 0.8×	1.2k 0.8×	719 0.9×	162	6.9k
Gunhild M. Mælandsmo Norway	49	2.4k 0.5×	5.1k 1.2×	3.3k 0.9×	1.3k 0.8×	725 0.9×	219	8.7k
Dominic T. Moore United States	42	2.8k 0.5×	2.7k 0.6×	3.5k 1.0×	2.1k 1.2×	369 0.5×	128	8.0k
Malcolm Ranson United Kingdom	51	2.4k 0.5×	4.4k 1.0×	6.9k 1.9×	4.9k 3.0×	762 0.9×	181	11.4k

Countries citing papers authored by Evi Lianidou

Since Specialization

Citations

This map shows the geographic impact of Evi Lianidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evi Lianidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evi Lianidou more than expected).

Fields of papers citing papers by Evi Lianidou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evi Lianidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evi Lianidou. The network helps show where Evi Lianidou may publish in the future.

Co-authorship network of co-authors of Evi Lianidou

This figure shows the co-authorship network connecting the top 25 collaborators of Evi Lianidou. A scholar is included among the top collaborators of Evi Lianidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evi Lianidou. Evi Lianidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Georgoulias, Vasilis, et al.. (2024). Multiplex detection of ten ESR1 mutations and AKT1 E17K in breast cancer using digital PCR. SHILAP Revista de lepidopterología. 5. 100154–100154. 3 indexed citations

Balgkouranidou, Ioanna, Eleni Κ. Efthimiadou, Vassilis Georgoulias, et al.. (2024). NALCN Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients. Biomolecules. 14(12). 1514–1514.

Georgoulias, Vassilis, et al.. (2024). Development and validation of a multi-marker liquid bead array assay for the simultaneous detection of PIK3CA and ESR1 hotspot mutations in single circulating tumor cells (CTCs). Heliyon. 10(19). e37873–e37873. 3 indexed citations

Markou, Athina, Αreti Strati, Martha Zavridou, et al.. (2023). Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer. Scientific Reports. 13(1). 1258–1258. 37 indexed citations

Markou, Athina, Eleni Tzanikou, Galatea Kallergi, et al.. (2021). Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer. Frontiers in Cell and Developmental Biology. 9. 641978–641978. 13 indexed citations

Sfikakis, Petros P., Giannis Ampatziadis-Michailidis, Ourania Tsitsilonis, et al.. (2021). Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection. Frontiers in Immunology. 12. 10 indexed citations

Mastoraki, Sofia, Ioanna Balgkouranidou, Emily Tsaroucha, et al.. (2020). KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer. Molecular Oncology. 15(9). 2412–2422. 26 indexed citations

Nasiri‐Ansari, Narjes, Georgios K. Dimitriadis, Gerasimos Siasos, et al.. (2019). Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study. Nutrients. 12(1). 53–53. 3 indexed citations

Lianidou, Evi & Catherine Alix‐Panabières. (2017). Early detection of lung cancer based on DNA methylation analysis in sputum and plasma. Translational Cancer Research. 6(1). 1 indexed citations

10.

Mastoraki, Sofia, Αreti Strati, Eleni Tzanikou, et al.. (2017). ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment. Clinical Cancer Research. 24(6). 1500–1510. 126 indexed citations

11.

Khella, Heba, Andreas Scorilas, Evi Lianidou, et al.. (2015). Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma. American Journal Of Pathology. 185(3). 693–703. 56 indexed citations

12.

Markou, Athina, et al.. (2014). PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer. Clinical Cancer Research. 20(22). 5823–5834. 50 indexed citations

13.

Khella, Heba, Andrew H. Girgis, Andreas Scorilas, et al.. (2014). miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma. Journal of Molecular Diagnostics. 17(2). 136–144. 53 indexed citations

14.

Chimonidou, Maria, Galatea Kallergi, Vassilis Georgoulias, Danny R. Welch, & Evi Lianidou. (2013). Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells. Molecular Cancer Research. 11(10). 1248–1257. 46 indexed citations

15.

Ignatiadis, Michail, Galatea Kallergi, Maria Ntoulia, et al.. (2008). Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer. Clinical Cancer Research. 14(9). 2593–2600. 181 indexed citations

16.

Κroupis, Christos, et al.. (2006). Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clinical Biochemistry. 39(7). 727–731. 105 indexed citations

17.

Apostolaki, Stella, Maria Perraki, Eleni Politaki, et al.. (2006). Detection of HER2 and CK-19 mRNA-positive circulating tumor cells (CTCs) in the peripheral blood of patients with early stage breast cancer.. Cancer Research. 66. 1207–1207. 3 indexed citations

18.

Κroupis, Christos, et al.. (2006). Real-time PCR detection of BRCA1 5382insC mutation by melting curve analysis on the Lightcycler. Cancer Research. 66. 48–48. 1 indexed citations

19.

Mavroudis, Dimitris, Maria Perraki, Savvas Papadopoulos, et al.. (2004). Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer. Clinical Cancer Research. 10(24). 8185–8194. 109 indexed citations

20.

Talieri, Maroulio, et al.. (2001). Development of a quantitative luminometric hybridization assay for the determination of telomerase activity. Clinical Biochemistry. 34(4). 277–284. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact